Key Insights

Highlights

Success Rate

100% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 30/100

Termination Rate

0.0%

0 terminated out of 45 trials

Success Rate

100.0%

+13.4% vs benchmark

Late-Stage Pipeline

44%

20 trials in Phase 3/4

Results Transparency

33%

10 of 30 completed with results

Key Signals

10 with results100% success

Data Visualizations

Phase Distribution

39Total
Not Applicable (6)
Early P 1 (2)
P 1 (3)
P 2 (8)
P 3 (14)
P 4 (6)

Trial Status

Completed30
Not Yet Recruiting6
Unknown4
Recruiting3
Active Not Recruiting1
Suspended1

Trial Success Rate

100.0%

Benchmark: 86.6%

Based on 30 completed trials

Clinical Trials (45)

Showing 20 of 20 trials
NCT07822672Phase 4CompletedPrimary

Sulfur 7% Cream Compared With Permethrin 5% Cream for Treating Scabies in Adults

NCT07813611Not Yet Recruiting

Secondary Bacterial Infections and Nasal Colonization in Scabies and Atopic Dermatitis

NCT05875441Phase 2CompletedPrimary

Efficacy and Safety Study of Moxidectin in Adults With Scabies

NCT07506967Not ApplicableNot Yet Recruiting

Early Detection and AI-Based Management of Skin-Related Neglected Tropical Diseases in Sub-Saharan Africa by Frontline Health Workers

NCT07305961CompletedPrimary

National Study on the Epidemiology and Effectiveness of Therapies in the Treatment of Scabies

NCT05500326Phase 2Active Not Recruiting

Ivermectin Therapy for Scabies Infection in Children Younger Than 5 Years of Age (ITCHY Study)

NCT06918665Phase 1SuspendedPrimary

HEALTH Trial - Healthy Adult Evaluation of Ivermectin Bioequivalence: Infant Versus Standard Formulation

NCT07247630Early Phase 1Not Yet RecruitingPrimary

Comparison of Permethrin-Based Treatment Strategies Against Scabies in Infants and Young Children

NCT04332068Phase 2CompletedPrimary

Ivermectin Safety in Small Children

NCT06404333Phase 2CompletedPrimary

Evaluating Pediatric Ivermectin in Children Under 15 kg (EPIC-15)

NCT07145736Phase 4Recruiting

Moxidectin Versus Ivermectin as Mass Drug Administration for the Control of Onchocerciasis and Other Neglected Tropical Diseases

NCT07159373Phase 3Not Yet Recruiting

Better Options for Lymphatic Filariasis Treatment

NCT06896929Phase 2Not Yet RecruitingPrimary

Comparison of Permethrin and Ivermectin in Children Greater Than 6 Yrs Age for Treatment of Scabies

NCT05310734Phase 4RecruitingPrimary

PK and Safety Study of Natroba Topical Suspension 0.9% in Subjects 1 Month to 3 Years 11 Months of Age With Scabies

NCT06546579Early Phase 1RecruitingPrimary

Sensitivity of Self-collected Skin Sampling for Scabies: a Pilot Study

NCT02407782Phase 3CompletedPrimary

Oral Ivermectin Versus Topical Permethrin to Treat Scabies in Children and Adults

NCT06396507Phase 3CompletedPrimary

Sulfur vs. Different Regimes of Permethrin for Scabies

NCT06380452Phase 3Not Yet RecruitingPrimary

Therapy for Scabies With Two Differently Concentrated Permethrin Creams

NCT03905265Phase 2CompletedPrimary

Dose-finding Study of Moxidectin for Treatment of Scabies

NCT05862701Phase 1CompletedPrimary

Comparison of Topical 5% Permethrin and Topical 10% Sulfur in the Treatment of Scabies

Scroll to load more

Research Network

Activity Timeline